Milrinone Lactate Injection, Solution
Product Images NDC 0143-9374

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Milrinone Lactate (NDC 0143-9374). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hikma Pharmaceuticals Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Milrinone Structure (Milrinone Lactate Injection Usp For Novaplus 1)

Chemical structure of Milrinone Lactate showing its molecular arrangement with pyridine and nitrile groups, alongside the lactate component represented by CH3CHOHCOOH.*

FDA Label Image

444 (Milrinone Lactate Injection Usp For Novaplus 2)

Milrinone Lactate Injection, USP 10 mg/10 mL (1 mg/mL) single dose vial label for intravenous use, labeled by Hikma Pharmaceuticals USA Inc. The label states it does not contain a preservative and includes text about the composition and storage instructions, with the brand novaplus visible.*

FDA Label Image

446 (Milrinone Lactate Injection Usp For Novaplus 3)

Label for Milrinone Lactate Injection, USP, 10 mg/10 mL (1 mg/mL) intravenous solution by Hikma Pharmaceuticals USA Inc. The label indicates a 10 x 10 mL single-dose vial package and states no preservative is present. It provides usage instructions, storage conditions, and manufacturer information.*

FDA Label Image

445 (Milrinone Lactate Injection Usp For Novaplus 4)

Label for Milrinone Lactate Injection, USP 1 mg/mL (20 mg/20 mL) single-dose vial for intravenous use by Hikma Pharmaceuticals USA Inc. The label states each mL contains 1 mg milrinone equivalent and includes information on pH adjustment, dosage, and storage instructions. It also notes the vial does not contain a preservative.*

FDA Label Image

447 (Milrinone Lactate Injection Usp For Novaplus 5)

Label for Milrinone Lactate Injection, USP, 1 mg/mL (20 mg/20 mL) intravenous solution. The label indicates it is for IV use only, does not contain a preservative, and comes in 10 single-dose 20 mL vials. Manufactured by Hikma Farmacêutica (Portugal) and distributed by Hikma Pharmaceuticals USA Inc. Storage instructions and active ingredient formulation details are also included.*

FDA Label Image

Layout 1 (Milrinone Lactate Injection Usp For Novaplus 6)

Milrinone Lactate 1 mg/mL injection, solution label showing a QR code and text fields for GTIN, serial number (SN), expiration date (EXP), and lot number (LOT). The label includes identification codes typical for pharmaceutical traceability. Labeler is Hikma Pharmaceuticals USA Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.